Brief Introduction
Established in 1999, Guangdong Taienkang Pharmaceutical Co., Ltd. (hereinafter referred to as "T&K") has 7 wholly owned subsidiaries and 2 holding subsidiaries. It has a marketing network and sales force covering 28 provincial regions, over 2,000 hospitals, and 200,000 pharmacies. T&K is an innovation-driven pharmaceutical leader specializing in core drugs—"Eterva" Dapoxetine Hydrochloride Tablets, "Eterway" Tadalafil Tablets, Fishing Pill IV, and "Jolethin" Lecithin Complexlodine tablets—and advanced APIs like Acalabrutinib, Belzutifan, Berotralstat, Deucravacitinib, Elacestrant, Lumateperone, Avapritinib, Obicetrapib, and Pirtobrutinib. With a focus on R&D, lean manufacturing, and strict quality control, we deliver high-value medicines, traditional Chinese patent drugs, and medical devices.Its 26-year sales network spans 28 Chinese provinces and global markets including UK, Indonesia, Germany, Japan, and Nigeria, combiningg omni-channel management with innovative promotion models.T&K commits to strengthening five major product lines (Gastroenterology, Ophthalmology, Gender, Dermatology and Anti-aging) through endogenous R&D and strategic expansions, positioning itself as an innovation-driven leader in healthcare.
Products
YOUR HEALTH IS OUR CONCERN
ACCREDITATIONS
T&K hold various accreditations and certifications world-wide including the ISO9001: 2015 Management System Accreditation.
Our products are manufactured to a high standard and we fully adhere to good manufacturing practices. T&K are transparent with all our customers and will gladly provide all our certification paperwork upon request. We believe that our products are one of the best available on the market.
T&K CLIENTS
T&K are ready to do business with you. We sell to Wholesalers, Retail & Supermarket Chains, Hospitals, Healthcare Businesses, Medical Supply Chains, Public Sector Organisations, Local & Central Governments and both Corporate and SME Companies. For a no-obligation quotation and sample pack - Please email the T&K Support Team on info@tnkeuro.com
- Guangdong Taienkang Pharmaceutical Co., Ltd. (T&K) was founded in 1999 and is a comprehensive pharmaceutical enterprise (Stock Code 831173) engaged in R&D, production, sales and agent operation of pharmaceuticals/medical devices. Core products include "Fishingg Pill IV", "Eterva" Dapoxetine Hydrochloride tablets, "Eterway" Tadalafil Tablets and "Jolethin" Lecithin Complex lodine tablets.
- With subsidiaries Shandong Hubble Kisen and Jiangsu Bochuangyuan, T&K focuses on breakthrough therapies. Its CKBA - a first-in-class vitilligo treatment - has initiated Phase II trials, aiming to fill domestic market gaps with potential annual sales exceeding 10 billion RMB. The company also explores anti-aging through immune diagonstic kits via subsidiary T&K Biotechnology.
- T&K operates integrated bases for chemical/biological drugs, APIs, and medical devices across Anhui, Sichuan, and Guangdong. Its 26-year sales network spans 28 Chinese provinces and global markets including UK, Indonesia, Germany, Japan, and Nigeria, combiningg omni-channel management with innovative promotion models.
- T&K commits to strengthening five major product lines (Gastroenterology, Ophthalmology, Gender, Dermatology and Anti-aging) through endogenous R&D and strategic expansions, positioning itself as an innovation-driven leader in healthcare.
Contact us
Telephone: +44 (0)800 488 0342
E-mail: info@tnkeuro.com
Address: Imperial House, 8 Kean Street, London, WC2B 4AS